Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BAMS Angels Fund is a Belgian angel investment firm specialized in early-stage life sciences, biotechnology, and high-technology sectors. Founded in 2005 as Business Angels Matching Services (BAMS), the group was established to bridge the equity gap for startups in the Walloon region and broader European markets. The firm has managed multiple investment vehicles, most notably BAMS Angels Fund I and BAMS Angels Fund II, which provided both seed capital and strategic mentorship to innovative ventures. Its portfolio includes notable biotech and medtech companies such as Bone Therapeutics, Bio-Sourcing, and Ovizio. While its early funds are now closed, the group has been a foundational part of the Belgian life sciences investment ecosystem, with its leadership deeply involved in the prominent 'Be Angels' network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BAMS Angels Fund.